Thoracic Oncology Multidisciplinary Simulation Series 1
Simulation | English | 2026 | 2.5 hours
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered

Explore the complexities of thoracic cancer care through interactive, case-based simulations that reflect real-world clinical challenges. Designed primarily for professionals and trainees in radiation oncology, thoracic surgery, pulmonology, and pathology, the series also offers valuable insights for the broader multidisciplinary care team. Each virtual patient scenario invites learners to apply evidence-based strategies, strengthen clinical decision-making, and navigate key diagnostic and treatment considerations. Developed by global thoracic oncology experts, this series supports collaborative practice and the delivery of high-quality, multidisciplinary care across diverse clinical settings.

This series includes four case-based simulations:

  1. Radiation Oncology—“Frank”—I've had a cough that won't go away and lost about seven kilograms over the past two months without meaning to, though I feel alright otherwise. I'm worried about what it could be. Can you explain what's going on and what we do next?
  2. Pathology—“Kevin”—I have been short of breath and I have lost about 6 kilograms over the past three months without trying.
  3. Pulmonology—“Boris”—Honestly, I feel fine. I get a little short of breath when I push myself, but that is just my usual chest. I am only here because they found some spots on a scan I had for a cold, and now everyone seems worried about it.
  4. Thoracic Surgery—“Jin”—I feel well, but these spots on my lungs worry me. Can you explain to me what they are, and whether treatment will affect my breathing and my independence?
This activity is designed for multidisciplinary teams of medical oncologists, surgical oncologists, pathologists, histologists, clinical radiation oncologists, pulmonologists, radiologists and interventional radiologists, translational scientists, nurses, nurse practitioners, scientists, specialty pharmacists and physician assistants globally.
Upon, completion of this activity, the participants should be able to:

  • Recognize diagnostic and therapeutic challenges faced by radiation oncologists, thoracic surgeons, pulmonologists and pathologists in the management of thoracic malignancies.
  • Discuss multidisciplinary approaches for the management of thoracic cancer across different histologies and stages.
  • Illustrate differences in approach
Case Authors and Co-Authors
  • Radiation Oncology
    • Pranshu Mohindra, University Hospitals Seidman Cancer Center, Ohio, USA
    • Samuel Lichtman-Mikol, University Hospitals Seidman Cancer Center, Ohio, USA
    • Rohan Patel: Medical College of Wisconsin, Wisconsin, USA
  • Pulmonology
    • Gustavo Faibischew Prado: Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil
  • Pathology
    • Anja Roden, Mayo Clinic Rochester, Minnesota, USA
    • Tae-Jung Kim, Mayo Clinic Rochester, Minnesota, USA
  • Thoracic Surgery 
    • Calvin Ng, Chinese University of Hong Kong, Hong Kong
    • Clarence Chan, Chinese University of Hong Kong, Hong Kong

Reviewing Committee
  • Telma Sequira, Instituto Portugues de Oncologia de Lisboa Francisco Gentil Martins, Lisbon, Portugal
  • Sheena Bhalla, University of Texas Southwestern Medical Center, Texas, USA
  • Tracy Leong, Austin Hospital, Heidelberg, Australia
  • Tom Newsom-Davis, Chelsea and Westminster Hospital, London, UK
  • Ross Soo, National University Cancer Institute, Singapore
  • Fernando Lopez-Rios, Hospital Universitario HM Sanchinarro, Madrid, Spain 
  • Whitney Lewis, The University of Texas MD Anderson Cancer Center, Texas, USA
  • Morten Quist, University Hospital Copenhagen, Copenhagen, Denmark
  • Rudolf Huber, Ludwig-Maximilians-University of Munich, Munich, Germany
  • Long Jiang, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  • Merel Hennink, Longkanker Nederland, Utrecht, Netherlands
  • John Cannings, Rare Cancers Australia, New South Wales, Australia
The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
If you need assistance with this activity, please email: education@iaslc.org.
Powered By